¼¼°èÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå
Oculoplastic Surgery
»óǰÄÚµå : 1791753
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 177 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License)
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)


Çѱ۸ñÂ÷

¼¼°èÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀåÀº 2030³â±îÁö 147¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 106¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾È°ú ¼ºÇü ¼ö¼ú ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 147¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾È°ú ¼ºÇü ¼ö¼ú ±â°è´Â º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀ̸ç, CAGRÀº 4.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 86¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾È°ú ¼ºÇü ¼ö¼ú ÀÓÇöõÆ® ¹× ±×·¡ÇÁÆ® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 28¾ï ´Þ·¯, Áß±¹Àº CAGR 5.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀåÀº 2024³â¿¡ 28¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 24¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 5.4%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 4.8%¿Í 4.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.5%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¾È°ú ¼ºÇü ¼ö¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

±â´ÉÀû, ½É¹ÌÀû ¾ÆÀÌÄɾ¼­ ´« ¼ºÇü ¼ö¼úÀÌ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

¾È°ú ¼ºÇü ¼ö¼úÀº ´«²¨Ç®, ¾È¿Í, ´«¹°±æ, ¾È¸é ÁÖº¯ ±¸Á¶ÀÇ ±â´ÉÀû Àå¾Ö¿Í ¹Ì¿ëÀû ¹®Á¦ ¸ðµÎ¿¡ ´ëÀÀÇÏ´Â ¾È°úÀÇ Áß¿äÇÑ ÇÏÀ§ Àü¹® ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ´« °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ½Ã·Â±³Á¤¿¡ ±×Ä¡Áö ¾Ê°í ±¸Á¶Àû, ³ëÈ­Àû, ¿Ü»óÀû ¹®Á¦·Î È®´ëµÇ¸é¼­ ¾È°ú ¼ºÇü ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ´«²¨Ç®°Å»ó¼ú(¾È°Ë°Å»ó¼ú), ¾È°ËÇϼö ±³Á¤¼ú, ¾È¿Í°¨¾Ð¼ú, ´«¹°±æ Àç°Ç¼ú(´«¹°ÁÖ¸Ó´Ï ¼ºÇü¼ú), ¹Ì¿ë¼ºÇü µîÀÌ ÀÖÀ¸¸ç, °¢°¢ÀÇ ¼ö¼úÀº ÀÇÇÐÀû »óÅÂ¿Í È¯ÀÚ ÁÖµµÀÇ ¹Ì¿ëÀû ¸ñÇ¥¿¡ ¸Â°Ô Á¶Á¤µË´Ï´Ù. ¾È°ú¿Í ¼ºÇü¿Ü°ú Àü¹®ÀÇ´Â ¾È°ú¿Í ¼ºÇü¿Ü°ú¸¦ ¸ðµÎ ÈÆ·Ã¹ÞÀº µ¶Æ¯ÇÑ ÀÇ»ç·Î ´«²¨Ç®ÀÇ À§Ä¡ ÀÌ»ó, Á¾¾ç, °©»ó¼±¾Èº´Áõ, ¾È¸é½Å°æ¸¶ºñ µîÀÇ Ä¡·á¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â Àç°Ç°ú ¹Ì¿ëÀ̶ó´Â µÎ °¡Áö ±â´ÉÀ» °âºñÇϰí ÀÖ¾î Æ¯È÷ ºÏ¹Ì, À¯·´, ±×¸®°í ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ °í·ÉÈ­°¡ ÁøÇàµÇ´Â »ç¶÷µé »çÀÌ¿¡¼­ ³ôÀº Àα⸦ ´©¸®°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ´«ÀÇ ÇÇ·Î¿Í ¾È¿ÍÁÖÀ§ ³ëÈ­ Áõ»óÀÇ È®»êµµ ºñħ½ÀÀû ¹× ¿Ü°úÀû °­È­¼úÀ» ÁÖ·ù·Î ¸¸µé°í ÀÖ½À´Ï´Ù. »ç¶÷µéÀÌ ¿À·¡ »ì¸é¼­ ¿Ü¸ð¿¡ ³ôÀº °¡Ä¡¸¦ µÎ´Â °¡¿îµ¥, ÀÓ»óÀû Àå¾Ö¸¦ ÇØ°áÇϸ鼭 ÀþÀ½À» µÇã¾ÆÁÖ´Â ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´« ¼ºÇü ¼ö¼úÀº ȸº¹ ½Ã°£ ´ÜÃà, ÈäÅÍ ÃÖ¼ÒÈ­ ±â¼ú, ¿Ü·¡ Áø·á°¡ °¡´ÉÇÑ ¸¶ÃëÀÇ ¹ßÀüÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀüüÀûÀ¸·Î ÀÌ ºÐ¾ß´Â ±³Á¤ ÀÇ·á, ½Ã·Â ÀçȰ, ¹ÌÀû ȸÃáÀÇ ±³Â÷Á¡¿¡ ºü¸£°Ô ÀÚ¸® ÀâÀ¸¸ç ´Ü¼øÈ÷ ¸¼Àº ½Ã·Â»Ó¸¸ ¾Æ´Ï¶ó Çö´ëÀÇ ¾ÆÀÌÄɾ ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù.

Àα¸ Åë°è¿Í ¹Ì¿ë ±âÁØÀÇ º¯È­´Â Àü ¼¼°èÀûÀ¸·Î ´« ¼ºÇü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

´« ¼ºÇü ¼ö¼ú¿¡ ´ëÇÑ Àü ¼¼°è ¼ö¿ä Áõ°¡´Â Àα¸Åë°èÇÐÀû º¯È­, »çȸ°æÁ¦Àû º¯È­, ¾Æ¸§´Ù¿ò°ú °Ç°­¿¡ ´ëÇÑ ¹®È­Àû ÀνÄÀÇ º¯È­¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. °í¼Òµæ ±¹°¡¿¡¼­´Â Àα¸ °í·ÉÈ­·Î ÀÎÇØ ´«²¨Ç® ȸÃá°ú ±â´É ¹× ¿Ü¸ð¸¦ ¸ðµÎ ȸº¹ÇÏ´Â ´«²¨Ç® ±³Á¤ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ´«²¨Ç® ¼ºÇü¼úÀº 45¼¼ À̻󿡼­ °¡Àå ¸¹ÀÌ ½ÃÇàµÇ´Â ¼ºÇü¼ö¼ú Áß Çϳª·Î, ½Ã·ÂÀ» ¶³¾î¶ß¸®°í ÇǰïÇÑ ÀλóÀ» ÁÖ´Â ´«²¨Ç® óÁüÀ» ÇØ°áÇØ ÁÖ´Â ¼ö¼úÀÔ´Ï´Ù. µ¿½Ã¿¡ ÀþÀº Ãþ, ƯÈ÷ ¹Ð·¹´Ï¾ó ¼¼´ë¿Í Z¼¼´ë´Â º¸´Ù ±¤¹üÀ§ÇÑ ¿¹¹æÀû ¹Ì¿ë Àü·«ÀÇ ÀÏȯÀ¸·Î ´«½ç ¸®ÇÁÆ®, ´«¹Ø ÇÊ·¯, ÇǺΠŸÀÌÆ®´× Ä¡·á¿Í °°Àº Àúħ½ÀÀû ½Ã¼úÀ» ¼±ÅÃÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Çѱ¹, ÀϺ», Áß±¹°ú °°Àº Áö¿ª¿¡¼­´Â ´« ¼ºÇü¼úÀÌ ´ëĪ, ´« Å©±â °­Á¶, ÀþÀº ¾ó±¼ À±°ûÀÇ ÀÌ»ó°ú ¹®È­ÀûÀ¸·Î ÀÏÄ¡ÇÏ¿© ½ÃÀåÀ» ´õ¿í È®´ëÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹ÀÇ Áß»êÃþ Áõ°¡´Â ÀÇ·á °ü±¤ Áõ°¡¿Í ¼÷·ÃµÈ ÀÇ·áÁøÀÇ °¡¿ë¼º°ú ÇÔ²² ´« ¼ºÇü ¼ö¼úÀ» ±× ¾î´À ¶§º¸´Ù ½±°Ô Á¢ÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÇÑÆí, °©»ó¼± °ü·Ã ¾ÈÁúȯ, ¼±Ãµ¼º ´«²¨Ç® ÀÌ»ó, »ç°í ¹× ½ºÆ÷Ã÷ ¿Ü»ó µî Áõ°¡°¡ Àç°Ç¼ö¼úÀÇ ±ÞÁõ¼¼¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¹Ìµð¾îÀÇ Ç¥Çö, ¼Ò¼È ¹Ìµð¾îÀÇ ÇÊÅÍ, ÀÎÇ÷ç¾ð¼­ ¹®È­µµ ´« ¼ºÇü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½Ã۴µ¥ ¹Ì¹¦ÇÏÁö¸¸ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼¼°è ¹ÌÀÇ ±âÁØÀÌ ÀÚ¿¬½º·´°í ¹Ì¹¦ÇÑ ¹ÌÀû º¯È­¸¦ °è¼Ó ¹Þ¾ÆµéÀÌ´Â °¡¿îµ¥, ´« ¼ºÇü ¼ö¼úÀº ÇüÅÂ, ±â´É, ¾ó±¼ÀÇ Á¶È­·Î¿î ±ÕÇüÀ» Ãß±¸ÇÏ´Â »ç¶÷µé¿¡°Ô ¸Å·ÂÀûÀÎ ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÌ ´« ¼ºÇü ¼ö¼úÀÇ Á¤È®¼º°ú °á°ú¸¦ À籸¼ºÇϰí Àִ°¡?

¼ö¼ú ±â¼ú, ¿µ»ó Áø´Ü, »ýü Àç·áÀÇ Çõ½ÅÀº ´« ¼ºÇü ¼ö¼úÀÇ ¾ÈÀü¼º, Á¤È®¼º, °á°ú¸¦ Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¾È¿Í CT ½ºÄµ, 3D ¾È¸é ¸ÅÇÎ, ¼ö¼ú Áß ³»ºñ°ÔÀÌ¼Ç µµ±¸¿Í °°Àº °íÇØ»óµµ ¿µ»ó ½Ã½ºÅÛÀ» ÅëÇØ ¿Ü°úÀÇ»ç´Â ƯÈ÷ º¹ÀâÇÑ ¾È¿Í Àç°Ç ¹× ´«¹°±æ ¼ö¼ú¿¡¼­ ¸Å¿ì Á¤È®ÇÑ ¼ö¼ú °èȹÀ» ¹Ì¸® ¼¼¿ï ¼ö ÀÖ½À´Ï´Ù. ·Îº¿°øÇаú ÄÄÇ»ÅÍ Áö¿ø ¹Ì¼¼¼ö¼úÀÇ ÅëÇÕÀº Á¼Àº ÇØºÎÇÐÀû °ø°£¿¡¼­ÀÇ Á¶ÀÛ¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ÀϺΠ¼ö¼ú¿¡ Á¡Â÷ÀûÀ¸·Î µµÀԵǰí ÀÖ½À´Ï´Ù. CO2 ·¹ÀÌÀú¿Í Er, YAG ·¹ÀÌÀú¸¦ Æ÷ÇÔÇÑ ·¹ÀÌÀú ±â¼úÀº ÃâÇ÷°ú ´Ù¿îŸÀÓÀ» ÃÖ¼ÒÈ­Çϸ鼭 ÇǺΠÀçÇ¥¸é, Àý°³, Á¶Á÷ ŸÀÌÆ®´×¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Àç·á Ãø¸é¿¡¼­´Â »ýü°øÇÐ ÀÌ½ÄÆí, Èí¼ö¼º ºÀÇÕ»ç, Á¶Á÷ Á¢ÂøÁ¦ÀÇ °³¹ß·Î Ä¡À¯°¡ °³¼±µÇ°í Àç¼ö¼úÀÇ Çʿ伺ÀÌ °¨¼ÒÇß½À´Ï´Ù. ¶ÇÇÑ, ´ÙÇ÷¼ÒÆÇ Ç÷Àå(PRP)°ú Áٱ⼼Æ÷ °­È­ ¿ä¹ýÀº ƯÈ÷ ¾Æ·¡ ´«²¨Ç®ÀÇ ÇÔ¸ôÀ̳ª ¿Ü»ó ÈÄ º¯Çü µîÀÇ Àç»ý ÀÀ¿ëÀ» À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á¿Í AI Áø´ÜÀÇ ºÎ»óÀº ¿ø°Ý Áø·á, ¼ö¼ú Àü °èȹ, ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô Çϰí, ¾È°ú ¼ºÇü Ä¡·á¸¦ º¸´Ù Ä£¼÷Çϰí Áö¼ÓÀûÀ¸·Î °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. Áõ°­Çö½Ç(Augmented Reality) µµ±¸´Â ÇöÀç ¼ö¼ú °á°ú ½Ã¹Ä·¹ÀÌ¼Ç ¹× ¼ö¼ú ÈÆ·ÃÀÇ ÁöħÀ¸·Î ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ȯÀÚÀÇ ¾ÈÀü°ú ¸¸Á·µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, ¿Ü°úÀǻ簡 ¹üÀ§¸¦ ³ÐÈ÷°í ÀϰüµÇ°Ô ³ôÀº ǰÁúÀÇ °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¾È°ú ¼ºÇü ¼ö¼úÀÌ ±â¼úÀûÀ¸·Î ´õ¿í ¹ßÀüÇÔ¿¡ µû¶ó, ¾È°ú ¼ºÇü ¼ö¼úÀº Æ´»õ ½ÃÀåÀ̳ª ¼±ÅÃÀûÀ̶ó´Â ÀνĿ¡¼­ ¹þ¾î³ª ÅëÇÕÀûÀÎ ¾È±¸ ¹× ¾ó±¼ °Ç°­ °ü¸®¿¡¼­ º¸´Ù ±¤¹üÀ§ÇÑ ¿ªÇÒ·Î ³ª¾Æ°¡°í ÀÖ½À´Ï´Ù.

´« ¼ºÇü ¼ö¼ú ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

´« ¼ºÇü ¼ö¼ú ½ÃÀåÀÇ ¼ºÀåÀº ÀÓ»ó ¹ßÀü, ¹Ì¿ë Æ®·»µå, ȯÀÚ Àα¸ Åë°è, ÀÇ·á ½Ã½ºÅÛÀÇ ¹ßÀü°ú °ü·ÃµÈ ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °¡Àå Å« ÃËÁø¿äÀÎ Áß Çϳª´Â ÇǺΠÀÌ¿ÏÁõ, ´«²¨Ç® óÁü, ´«²¨Ç® ÀÌ¿ÏÁõ°ú °°Àº ³ëÈ­¿¡ µû¸¥ ±â´ÉÀû »óÅ Áõ°¡·Î ½Ã¾ß¿Í Æí¾ÈÇÔÀ» ȸº¹Çϱâ À§ÇØ ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù. µ¿½Ã¿¡ ³²³à ¸ðµÎ ¹Ì¿ë¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¹Ì¿ëÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ëµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ´« ¼ºÇüÀÇ ¼±ÅÃÀû °³¼±À» ¿øÇϴ ȯÀÚÃþÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº ¶Ç ´Ù¸¥ Å« ÃËÁøÁ¦ÀÔ´Ï´Ù. ÃÖ¼Òħ½ÀÀû ±â¼ú, ³»½Ã°æ Á¢±Ù, Á¶Á÷ º¸Á¸ µµ±¸´Â ȸº¹ ½Ã°£°ú ¼ö¼ú À§ÇèÀ» ȹ±âÀûÀ¸·Î °¨¼Ò½ÃÄÑ ´õ ¸¹Àº ȯÀڵ鿡°Ô ¸Å·ÂÀûÀÎ ½Ã¼úÀÌ µÇ°í ÀÖ½À´Ï´Ù. °³ÀÎÈ­µÈ Ä¡·á¿Í ÀÚ¿¬½º·¯¿î ¸¶¹«¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿Ü°úÀÇ»çµéÀº ÷´Ü ¿µ»ó Áø´Ü°ú ¸ÂÃãÇü ¼ö¼ú °èȹÀ» äÅÃÇÏ¿© ȯÀÚ ¸¸Á·µµ¸¦ ³ôÀ̰í ÀÔ¼Ò¹®À» ÅëÇÑ ÃßõÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿Í ¿Ü·¡ Áø·á¼ÒÀÇ ±ÞÁõÀº ƯÈ÷ µµ½Ã Áö¿ª¿¡¼­ ´« ¼ºÇü ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼º°ú °æÁ¦¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀϺΠ±¹°¡¿¡¼­´Â ±â´ÉÀû ¼ö¼ú¿¡ ´ëÇÑ º¸Çè Àû¿ëÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌÀü¿¡´Â ¹Ì¿ëÀûÀÎ ¸ñÀûÀ¸·Î¸¸ ¿©°ÜÁ³´ø Áõ»ó¿¡ ´ëÇÑ Ä¡·á°¡ ´õ¿í Ȱ¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿Ü»óÀ¸·Î ÀÎÇÑ ¾È¸é ¼Õ»ó, ¼±Ãµ¼º Áúȯ, ´Ù¸¥ ¾È°ú ¼ö¼ú·Î ÀÎÇÑ ÇÕº´Áõ ¹ß»ý·ü Áõ°¡µµ Àç°Ç ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ±³À° ÇÁ·Î±×·¥, ÀÎÁõ, ´ÙÇÐÁ¦Àû Çù¾÷¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â Àü ¼¼°è ¾È°ú ¼ºÇü¿Ü°ú ÀÇ»çÀÇ Áú°ú ½Å·Úµµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¸¦ Á¾ÇÕÇØ º¼ ¶§, ¼¼°è ½ÃÀåÀÇ È®´ë°¡ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ¾È°ú ¼ºÇü ¼ö¼úÀÌ Á¾ÇÕÀûÀÎ ¾È°ú ÀÇ·á ¹× ¾È¸é ÀÇ·áÀÇ ¹Ì·¡¿¡¼­ Áß¿äÇÑ ÃàÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(¾È°ú ¼ºÇü ¼ö¼ú ±â±¸, ¾È°ú ¼ºÇü ¼ö¼ú ÀÓÇöõÆ®£¦±×·¡ÇÁÆ®, ¾È°ú ¼ºÇü ¼ö¼ú ±â±â);½Ã¼ú(¾È°Ë ½º½½, ÆäÀ̽º ¸®ÇÁÆ® ½Ã¼ú, ´«½ç ¸®ÇÁÆ®/À̸¶ ¸®ÇÁÆ® ½Ã¼ú, ¼Ò¾Æ ¾È°ú ¼ºÇü ½º½½, ¾È¿Í ½º½½);ÃÖÁ¾»ç¿ëÀÚ(¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ÃÖÁ¾»ç¿ëÀÚ, º´¿ø£¦Å¬¸®´Ð ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø·Î ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Oculoplastic Surgery Market to Reach US$14.7 Billion by 2030

The global market for Oculoplastic Surgery estimated at US$10.6 Billion in the year 2024, is expected to reach US$14.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Oculoplastic Surgery Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Oculoplastic Surgery Implants & Grafts segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.4% CAGR

The Oculoplastic Surgery market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Oculoplastic Surgery Market - Key Trends & Drivers Summarized

Why Is Oculoplastic Surgery Becoming a Focal Point in Functional and Aesthetic Eye Care?

Oculoplastic surgery is emerging as a critical subspecialty within ophthalmology, addressing both functional impairments and cosmetic concerns of the eyelids, orbit, tear ducts, and surrounding facial structures. As awareness of eye health expands beyond vision correction to include structural, age-related, and trauma-induced issues, the demand for oculoplastic procedures is steadily increasing. These surgeries include eyelid lifts (blepharoplasty), ptosis repair, orbital decompression, tear duct reconstructions (dacryocystorhinostomy), and cosmetic enhancements-each tailored to address both medical conditions and patient-driven aesthetic goals. Oculoplastic surgeons, uniquely trained in both ophthalmic and plastic surgery, play a pivotal role in treating conditions such as eyelid malpositions, tumors, thyroid eye disease, and facial paralysis. The dual nature of the field-combining reconstructive and aesthetic functions-has made it highly sought-after among an aging population, particularly in North America, Europe, and increasingly in Asia-Pacific. The growing prevalence of digital eye strain and periorbital aging symptoms has also made non-invasive and surgical enhancements more mainstream. With people living longer and placing higher value on appearance, procedures that restore youthfulness while addressing clinical impairments are in high demand. Moreover, oculoplastic surgery is gaining popularity due to shorter recovery times, minimal scarring techniques, and advancements in anesthesia that enable outpatient care. Altogether, the field is rapidly positioning itself at the intersection of corrective medicine, visual rehabilitation, and aesthetic rejuvenation, redefining modern eye care as more than just clear vision.

How Are Shifting Demographics and Beauty Standards Shaping Oculoplastic Demand Globally?

The rise in global demand for oculoplastic surgery is being heavily influenced by demographic shifts, socio-economic changes, and evolving cultural perceptions of beauty and wellness. In high-income countries, the aging population is driving demand for eyelid rejuvenation and corrective procedures that restore both function and appearance. Blepharoplasty, for instance, is one of the most commonly performed cosmetic surgeries among individuals aged 45 and older, addressing sagging eyelids that impair vision or contribute to a fatigued appearance. At the same time, younger demographics-especially millennials and Gen Z-are increasingly opting for minimally invasive procedures such as brow lifts, under-eye fillers, and skin-tightening treatments as part of a broader preventive aesthetic strategy. In regions like South Korea, Japan, and China, oculoplastic procedures are culturally aligned with ideals of symmetry, eye size enhancement, and youthful facial contours, further expanding the market. The growing middle class in emerging economies, coupled with increased medical tourism and availability of skilled practitioners, has made oculoplastic surgery more accessible than ever before. Meanwhile, the global rise in thyroid-related eye conditions, congenital eyelid anomalies, and trauma cases from accidents or sports injuries is supporting a parallel surge in reconstructive procedures. Media representation, social media filters, and influencer culture are also playing a subtle but significant role in amplifying demand for cosmetic eye enhancements. As global beauty standards continue to embrace natural-looking, subtle aesthetic changes, oculoplastic surgery is becoming an appealing option for those seeking balance between form, function, and facial harmony.

Is Technology Reshaping the Precision and Outcomes of Oculoplastic Procedures?

Innovation in surgical technology, imaging, and biomaterials is profoundly enhancing the safety, precision, and outcomes of oculoplastic surgery. High-resolution imaging systems such as orbital CT scans, 3D facial mapping, and intraoperative navigation tools allow surgeons to pre-plan procedures with extreme accuracy, especially in complex orbital reconstructions or tear duct surgeries. The integration of robotics and computer-assisted microsurgery is gradually being introduced for select procedures, offering better maneuverability in tight anatomical spaces. Laser technologies, including CO2 and Er:YAG lasers, are now widely used for skin resurfacing, incision making, and tissue tightening with minimal bleeding and downtime. In terms of materials, the development of bioengineered grafts, absorbable sutures, and tissue adhesives has improved healing and reduced the need for revision surgeries. Additionally, platelet-rich plasma (PRP) and stem cell-enriched therapies are being explored for regenerative applications, particularly in cases of lower eyelid hollowing and post-traumatic deformities. The rise of telehealth and AI-driven diagnostics is also facilitating remote consultations, pre-operative planning, and post-surgical monitoring, making oculoplastic care more accessible and continuous. Augmented reality tools are now being explored to help simulate procedural outcomes and guide surgical training. These advancements are not only improving patient safety and satisfaction but are also enabling surgeons to expand their scope and deliver consistently high-quality outcomes. As oculoplastic surgery becomes more technologically enabled, it is shedding the perception of being niche or elective and stepping into a broader role within integrative eye and facial healthcare.

What Are the Key Drivers Fueling the Global Growth of the Oculoplastic Surgery Market?

The growth in the oculoplastic surgery market is driven by several factors linked to clinical advancements, aesthetic trends, patient demographics, and health system developments. One of the foremost drivers is the global rise in age-related functional conditions such as dermatochalasis, ptosis, and eyelid laxity, which necessitate surgical intervention to restore visual field and comfort. Simultaneously, cosmetic awareness and increasing acceptance of aesthetic procedures among both men and women are expanding the patient pool seeking elective oculoplastic enhancements. Technological innovation is another major catalyst-minimally invasive techniques, endoscopic access, and tissue-sparing tools have dramatically reduced recovery time and surgical risks, making the procedures more appealing to a wider audience. The growing emphasis on personalized care and natural-looking outcomes is pushing surgeons to adopt advanced imaging and customized surgical planning, improving patient satisfaction and driving word-of-mouth referrals. Additionally, the surge in outpatient surgical centers and ambulatory clinics is increasing the accessibility and affordability of oculoplastic procedures, especially in urban markets. Insurance coverage for functional surgeries is expanding in several countries, further incentivizing treatment for conditions previously considered cosmetic. The rising incidence of trauma-related facial injuries, congenital disorders, and complications from other ocular surgeries also supports demand in reconstructive applications. Finally, increasing investments in training programs, certifications, and interdisciplinary collaborations are elevating the quality and credibility of oculoplastic surgeons worldwide. Collectively, these interwoven trends are accelerating the global market’s expansion and establishing oculoplastic surgery as a key pillar in the future of comprehensive eye and facial care.

SCOPE OF STUDY:

The report analyzes the Oculoplastic Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Oculoplastic Surgery Instruments, Oculoplastic Surgery Implants & Grafts, Oculoplastic Surgery Equipment); Procedure (Eyelid Surgery Procedure, Facelift Procedure, Brow Lift / Forehead Lift Procedure, Pediatric Oculoplastic Surgery Procedure, Orbital Surgery Procedure); End-Use (Ambulatory Surgery Centers End-Use, Hospitals & Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â